Stockscreener 앱 받기
16.75
2.45%
0.40
시간 외 거래:
17.42
0.67
+4.00%
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Can momentum traders help lift Quantum BioPharma Ltd.Trade Risk Assessment & Weekly High Conviction Ideas - Newser
What to do if you’re stuck in Quantum BioPharma Ltd.Quarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Earnings visualization tools for Quantum BioPharma Ltd.July 2025 Macro Moves & Safe Capital Growth Stock Tips - Newser
How to integrate Quantum BioPharma Ltd. into portfolio analysis toolsJuly 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Quantitative breakdown of Quantum BioPharma Ltd. recent moveWeekly Market Report & Reliable Price Breakout Signals - Newser
Will Quantum BioPharma Ltd. price bounce be sustainableWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser
Published on: 2025-08-26 14:35:38 - Newser
What earnings revisions data tells us about Quantum BioPharma Ltd.Trade Risk Summary & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-08-26 10:02:19 - Newser
Will Quantum BioPharma Ltd. stock recover after recent drop2025 Top Gainers & Stepwise Trade Signal Implementation - Newser
What momentum shifts mean for Quantum BioPharma Ltd.July 2025 Pullbacks & High Accuracy Investment Signals - Newser
Quantum BioPharma : Proxy Card - MarketScreener
Can a trend reversal in Quantum BioPharma Ltd. lead to recoveryTreasury Yields & Low Drawdown Trading Techniques - Newser
Advanced analytics toolkit walkthrough for Quantum BioPharma Ltd.2025 Major Catalysts & Smart Allocation Stock Tips - Newser
Technical signs of recovery in Quantum BioPharma Ltd.July 2025 Review & AI Optimized Trade Strategies - Newser
What moving averages say about Quantum BioPharma Ltd.New Guidance & Smart Investment Allocation Insights - Newser
How volatile is Quantum BioPharma Ltd. stock2025 Market Outlook & Weekly Watchlist of Top Performers - theviewers.co.kr
Price action breakdown for Quantum BioPharma Ltd.Quarterly Performance Summary & AI Powered Buy and Sell Recommendations - Newser
Volume spikes in Quantum BioPharma Ltd. stock – what they meanTrade Risk Report & Target Return Focused Stock Picks - Newser
Quantum BioPharma Ltd. Stock Lags Behind Sector BenchmarksJuly 2025 Decliners & Low Risk Investment Opportunities - beatles.ru
What indicators show strength in Quantum BioPharma Ltd.Jobs Report & Verified Short-Term Plans - Newser
Market Recap: Does Quantum BioPharma Ltd. have strong fundamentalsQuarterly Trade Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Quantum Biopharma shares rise 5.10% after-hours after announcing debt settlement and corporate updates. - AInvest
Quantum BioPharma Announces Key Corporate Updates - TipRanks
Quantum BioPharma Announces Corporate Updates - GlobeNewswire
Is Quantum BioPharma Ltd. stock entering bullish territorySwing Trade & Smart Investment Allocation Tips - Newser
What technical models suggest about Quantum BioPharma Ltd.’s comebackMarket Sentiment Review & Comprehensive Market Scan Reports - Newser
Momentum Indicator Shows Bearish Divergence in Quantum BioPharma Ltd.2025 Trading Volume Trends & Long-Term Investment Growth Plans - newsyoung.net
How to escape a deep drawdown in Quantum BioPharma Ltd.Weekly Market Summary & Reliable Breakout Stock Forecasts - Newser
Real time social sentiment graph for Quantum BioPharma Ltd.Insider Buying & AI Based Buy/Sell Signal Reports - Newser
Quantum Biopharma shares rise 2.45% premarket after GC Biopharma signed an MOU with Thai Red Cross Society. - AInvest
Institutional scanner results for Quantum BioPharma Ltd.Earnings Overview Report & Stock Market Timing Techniques - Newser
How sentiment analysis helps forecast Quantum BioPharma Ltd.July 2025 Big Picture & Reliable Entry Point Trade Alerts - Newser
Ranking Quantum BioPharma Ltd. among high performing stocks via toolsRisk Management & Long Hold Capital Preservation Tips - Newser
Quantum Biopharma Ltd. shares fall 2.99% intraday amid federal budget cuts and VC funding into oncology ventures. - AInvest
Quantum Biopharma shares rise 3.09% premarket after corporate restructuring and VC funding in oncology ventures. - AInvest
Quantum Biopharma Ltd. shares fall 1.08% intraday as China pharma firms turn to local reagent suppliers. - AInvest
What makes Quantum BioPharma Ltd. stock price move sharplyFree Real-Time Stock Signals - classian.co.kr
Quantum Biopharma shares rise 4.19% premarket after signing an agreement to manufacture oral drug formulation of Lucid-MS. - AInvest
Quantum BioPharma Ltd. Advances MS Treatment with CDMO Agreement for Lucid-MS - citybuzz -
Quantum BioPharma to seek shareholder approval for private placement - Investing.com
Quantum BioPharma Announces Update to Previously Announced Private Placement - Newsfile
Quantum BioPharma Signs Agreement to Manufacture Oral Drug - GlobeNewswire
Quantum BioPharma (QNTM) Shares Soar as Lead Drug Candidate Lucid-MS Nears Phase 2 Trial - AInvest
Why Quantum BioPharma (QNTM) Stock Is Soaring Today - 富途牛牛
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial - Lelezard
Why Is Quantum BioPharma In The News Today? Here’s An Important Update On Its Multiple Sclerosis Investigational Drug By Stocktwits - Investing.com India
Quantum Biopharma's Lucid-MS: A Neuroprotective Revolution in MS Treatment? - AInvest
Quantum Biopharma Seals Deal to Manufacture Oral Lucid-MS Ahead of Phase 2 Trial - MarketScreener
Quantum BioPharma Advances Lucid-MS for Phase 2 MS Trial - TipRanks
0.98%
8.06%
자본화:
|
볼륨(24시간):